News Releases

January 3, 2019
Neon Therapeutics Provides Business Update and Outlook for 2019
CAMBRIDGE, Mass. , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today provided a business update and outlook for 2019. “We have an exciting year ahead of us in 2019, with multiple data
Additional Formats